secwatch.observer — SEC 8-K summary
======================================

Issuer:     MARIMED INC. (MRMD)
CIK:        0001522767
Form:       8-K
Filed at:   2026-05-13T21:13:09+00:00
Accession:  0001522767-26-000070
Event type: earnings
Sentiment:  positive
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MariMed Q1 revenue $39.5M (+4.2% YoY); net loss narrows to $3.8M; adj. EBITDA $3.6M
--------------------------------------------------------------------------------

- Revenue $39.5M, up 4.2% YoY from $37.9M.
- GAAP net loss $3.8M, improved from $5.5M loss in prior year.
- Non-GAAP net loss $3.2M, improved from $3.9M.
- Adjusted EBITDA $3.6M (9% margin) vs $2.5M (7% margin) YoY.
- Gross margin slightly declined: GAAP 39% (vs 40%), Non-GAAP 40% (vs 41%).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1522767/000152276726000070/0001522767-26-000070-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1522767/000152276726000070/mrmd-20260513.htm
  HTML page:      https://secwatch.observer/filing/0001522767-26-000070

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer